FDA Inspection 1068504 — Jing Zhou Hou, MD, PhD

Jing Zhou Hou, MD, PhD — FEI 3014000219

The FDA completed an inspection of Jing Zhou Hou, MD, PhD on Oct 12, 2018 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 12, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pittsburgh, PA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.